<DOC>
	<DOCNO>NCT01034111</DOCNO>
	<brief_summary>This study ass , 4-week treatment period , safety efficacy addition sitagliptin metformin participant type 2 diabetes mellitus ( T2DM ) fail achieve glycemic control metformin monotherapy .</brief_summary>
	<brief_title>A Local Experiential Study With Sitagliptin ( Antihyperglycemic Drug ) 30 Patients With Type 2 Diabetes Mellitus ( 0431-178 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Participants T2DM fail metformin monotherapy Between age 18 79 Participants history type 1 Diabetes Mellitus ketoacidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>